The newly engineered high-fidelity Cas9 variant with no detectable off-target effects provides a further advance for the potential therapeutic application of CRISPR/Cas9 genome editing tools [80]

The newly engineered high-fidelity Cas9 variant with no detectable off-target effects provides a further advance for the potential therapeutic application of CRISPR/Cas9 genome editing tools [80]. spotlight the introduction of genome editing in HSCs and critically view the use of HSCs in non-hematopoietic tissue regeneration. Key Words: Hematopoietic stem cells, Autologous and allogeneic transplantation, Hematopoietic […]